https://secure.sherbornegibbs.com/bjdvd/pdf/1202.

pdf

http://journal.diabetes.org/clinicaldiabetes/v15n3M-J97/pg102.htm

http://care.diabetesjournals.org/content/31/Supplement_2/S125
Bethel MA, Feinglos MN (2005). Basal Insulin Therapy in Type 2
Diabetes. J. Am. Board Fam. Pract. 18: 199-204.

Cook MN, Girman GJ, Stein PP, Alexander CM, Holman RR (2005).
Glycemic Control Continuous to Deteriorate After Sulphonylurea are
Added to Metformin Among Patients With Type 2 Diabetes. Diabetes
Care
28: 5.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey

G (2006). Triple Therapy in Type 2 Diabetes, Insulin Glargine or
Roziglitazone added to Combination Therapy of Sulfonylurea plus
Metformin in Insulin-Naïve Patients. Diabetes Care 29: 554-559.

http://www.diabetesincontrol.com/increased-mortality-with-combining-sulfonylurea-and-insulin/

http://eprints.usm.my/10179/1/EVALUATION_OF_METFORMIN_USAGE_IN.pdf

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571051/

https://www.ncbi.nlm.nih.gov/pubmed/25205223

http://mfi.farmasi.ugm.ac.id/files/news/9._2_Kolom_Tri_Murti_R_.pdf

http://care.diabetesjournals.org/content/suppl/2014/12/23/38.Supplement_1.DC1/January_Supplemen
t_Combined_Final.6-99.pdf (ADA)